Argonne OutLoud: ‘Shining a Light on Drug Discovery’
Advanced Photon Source (APS) users Lisa Keefe and Vincent Stoll will present “Shining a Light on Drug Discovery” Thursday, June 22, 2017, at 6 p.m. at Argonne National Laboratory, Bldg. 402 APS Auditorium, 9700 S. Cass Avenue, Argonne, IL. This lecture is free and open to the public. A Q&A will follow the presentation.
Keefe, director of the IMCA-CAT (Industrial Macromolecular Crystallography Association–Collaborative Access Team) at the Advanced Photon Source, and Stoll, associate director, Structural Biology, AbbVie, Inc., will explain how X-ray light advances the complex work of drug discovery.
Argonne employees are encouraged to attend and bring their family and friends. Attendees 16 and older must register in advance.
Non-U.S. citizens: As additional time is required to process non-U.S. visitor access to Argonne’s campus, please register no later than two weeks prior to the event.
If you have questions about the OutLoud Lecture Series, contact us at (630) 252-5501 or email.
Reception featuring light snack, interactive activity and research artifacts: 6-7 p.m.
Lecture and audience Q&A: 7-8 p.m.
Light is revelatory and can be critical to obtaining the knowledge needed to improve the human experience. Light from the APS at Argonne, one of the brightest light sources in the world, reveals new insights that have allowed scientists to develop life-saving and life-enhancing drugs.
About the Presenters
Lisa Keefe is director of the IMCA-CAT (Industrial Macromolecular Crystallography Association–Collaborative Access Team) at the Advanced Photon Source and vice president for Advancing Therapeutics at Hauptman-Woodward Medical Research Institute. Her research activities focus on accelerating drug discovery through synchrotron-based structural biology.
Vincent Stoll is a Research Fellow and associate director of Structural Biology in Pharmaceutical Discovery at AbbVie. His research focuses on structure-based drug design of small molecules and biologics across all therapeutic areas of pharmaceutical discovery at AbbVie.